Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication

被引：0
|
作者：
Caifeng Shi
Yemeng Wan
Aiqin He
Xiaomei Wu
Xinjia Shen
Xueting Zhu
Junwei Yang
Yang Zhou
机构：
[1] Second Affiliated Hospital of Nanjing Medical University,Center for Kidney Disease
来源：
Acta Diabetologica | 2023年 / 60卷
关键词：
Metabolite; Inflammation; Kidney;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1199 / 1207
页数：8
相关论文
共 50 条
  • [1] Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication
    Shi, Caifeng
    Wan, Yemeng
    He, Aiqin
    Wu, Xiaomei
    Shen, Xinjia
    Zhu, Xueting
    Yang, Junwei
    Zhou, Yang
    ACTA DIABETOLOGICA, 2023, 60 (09) : 1199 - 1207
  • [2] CHEMERIN, INFLAMMATION AND DIABETIC KIDNEY DISEASE PROGRESSION IN PATENTS WITH TYPE 2 DIABETES MELLITUS
    El-Tahir, Fatima
    Mohamed, Ali Moustafa Shendi
    Elgohary, Marwan
    Esh, Asmaa Mohammed
    Ghorab, Adel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1366 - 1366
  • [3] Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney Disease
    Cherney, David Z.
    Tuttle, Katherine R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (04): : 444 - 446
  • [4] Association of Diabetic Kidney Disease Markers and Urinary Beta-crossLaps in Type 2 Diabetes
    Arumugasamy, Lalithambigai
    Patel, Hetal G.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [5] Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes
    Zhu, Huanhuan
    Liu, Xi
    Zhang, Chengning
    Li, Qing
    An, Xiaofei
    Liu, Simeng
    Wu, Lin
    Zhang, Bo
    Yuan, Yanggang
    Xing, Changying
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (11)
  • [6] Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
    Dekker, Shosha E. I.
    Verhoeven, Aswin
    Soonawala, Darius
    Peters, Dorien J. M.
    de Fijter, Johan W.
    Mayboroda, Oleg A.
    PLOS ONE, 2020, 15 (05):
  • [7] Kidney Fat by Magnetic Resonance Spectroscopy in Type 2 Diabetes and Diabetic Kidney Disease
    Heinrich, Niels S.
    Pedersen, Rune P.
    Lindberg, Ulrich
    Andersen, Ulrik B.
    Haddock, Bryan
    Hansen, Tine
    Fornoni, Alessia
    Rossing, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 111 - 112
  • [8] Urinary proteomics and the effect of dapagliflozin treatment in persons with type 2 diabetes and diabetic kidney disease: a randomised crossover trial
    Ronkko, T. K. E.
    Eickhoff, M. K.
    Mischak, H.
    Rossing, P.
    Persson, F.
    Ahluwalia, T. S.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 106 - 106
  • [9] Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease
    Thethi, Tina K.
    Bajwa, Muhammad A.
    Ghanim, Husam
    Jo, Chanhee
    Weir, Monica
    Goldfine, Allison B.
    Umpierrez, Guillermo
    Desouza, Cyrus
    Dandona, Paresh
    Fang-Hollingsworth, Ying
    Raghavan, Vasudevan
    Fonseca, Vivian A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (03) : 433 - 437
  • [10] Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients
    Jiang, Xu
    Zhang, Qian
    Wang, Hua-Bin
    Cui, Xiao-Fan
    Liu, Rui
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (01)
12345